West Pharmaceutical Services | WST - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Align Technology USD 178.05M 46.66M 2026-03
Avanos Medical USD 8.9M 15.87M 2026-03
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 119.9M 44.08M 2026-03
Cooper Companies USD -31M 243.8M 2026-03
Dentsply International USD 32M 506M 2026-03
Haemonetics USD 67.4M 8.9M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
J&J USD 6.62B 1.03B 2026-03
Medtronic USD 2.09B 354M 2026-03
Merit Medical Systems USD 44.16M 10.04M 2026-03
Neogen USD -3.3M 2.08M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quidel USD -31.8M 5.5M 2026-03
Repligen USD 19.98M 13K 2026-03
Rockwell Medical USD 515K 1.84M 2024-06
Solventum Corp USD 85M 20M 2026-03
STAAR Surgical USD 17.4M 28.34M 2026-03
Terumo JPY 31.45B 12.43B 2026-03
Utah Medical Products USD 2.44M 1.32M 2025-12
West Pharmaceutical Services USD 177.1M 14.6M 2026-03